Kay, Jonathan
Cross, Raymond K.
Feldman, Steven R.
Park, Younjin
Hanauer, Stephen B.
Funding for this research was provided by:
Samsung Bioepis
Article History
Received: 5 September 2023
Accepted: 14 November 2023
First Online: 19 December 2023
Declarations
:
: Jonathan Kay has received research support paid to UMass Chan Medical School from Aker BioMarine AS; Biogen; Galapagos NV; Novartis Pharmaceuticals Corp.; and SetPoint Medical Corp. He has received consulting fees from AbbVie Inc.; Alvotech Swiss AG; Amgen Inc.; Boehringer Ingelheim GmbH; Bristol Myers Squibb Co.; Fresenius Kabi; Novartis Pharmaceuticals Corp.; Organon LLC; Pfizer Inc.; Samsung Bioepis; Sandoz Inc.; Scipher Medicine; Teijin Pharma Ltd.; UCB Inc.; Viatris Inc.; and Yuhan Corp. He has received fees for participation in independent data safety monitoring committees from Inmagene LLC and Kolon TissueGene, Inc. He has received royalties from Wolters Kluwer NV for UpToDate. Raymond K. Cross has received consulting fees or honoraria from Abbvie, BMS, Fresenius Kabi, Fzata, Janssen, Magellan Health, Option Care, Pfizer, Samsung Bioepis, Sandoz, Sebela, and Takeda. He received fees for participation in review activities from Adiso, serves as executive committee member in the IBD education group, and as scientific co-director for CorEvitas. Steven R. Feldman has received research, speaking and/or consulting support from Eli Lilly and Company, AbbVie, Janssen, Alvotech, vTv Therapeutics, Bristol-Myers Squibb, Samsung, Pfizer, Boehringer Ingelheim, Amgen, Dermavant, Arcutis, Novartis, UCB, Helsinn, Sun Pharma, Almirall, Galderma, Mylan, Forte, Arena, Biocon, Accordant, Argenx, Sanofi, Regeneron, the National Biological Corporation, Caremark, Teladoc, BMS, Ono, and Micreos. He is a founder and part owner of Causa Research and holds stock in Sensal Health. Younjin Park is an employee of Samsung Bioepis. Stephen B. Hanauer has received financial research, speaking, review, and/or consulting support from Abbvie, Allergan, Amgen, Arena, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Cosmos, Catalys Pacific, Covance, Genentech, GSK, Janssen, Lilly, Merck, Novartis, Pfizer, Progenity, Prometheus, Receptos, Salix, Samsung Bioepis, Seres Therapeutics, Sorriso, Takeda, TLL Pharma, UCB Pharma, VHsquared, Gossamer, Protagonist.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.